ArticleFrontiers in oncology2022

Case report: The effective response to pembrolizumab in combination with bevacizumab in the treatment of a recurrent glioblastoma with multiple extracranial metastases.

Gang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.